|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cohen PA, Jhingran A, Oaknin A and Denny
L: Cervical cancer. Lancet. 393:169–182. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Arbyn M, Weiderpass E, Bruni L, de Sanjosé
S, Saraiya M, Ferlay J and Bray F: Estimates of incidence and
mortality of cervical cancer in 2018: A worldwide analysis. Lancet
Glob Health. 8:e191–e203. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nagano T and Fraser P: No-nonsense
functions for long noncoding RNAs. Cell. 145:178–181. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hu YW, Kang CM, Zhao JJ, Nie Y, Zheng L,
Li HX, Li X, Wang Q and Qiu YR: LncRNA PLAC2 down-regulates RPL36
expression and blocks cell cycle progression in glioma through a
mechanism involving STAT1. J Cell Mol Med. 22:497–510. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yang L, Li Y, Gong R, Gao M, Feng C, Liu
T, Sun Y, Jin M, Wang D, Yuan Y, et al: The long non-coding
RNA-ORLNC1 regulates bone mass by directing mesenchymal stem cell
fate. Mol Ther. 27:394–410. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hu X, Goswami S, Qiu J, Chen Q, Laverdure
S, Sherman BT and Imamichi T: Profiles of long non-coding RNAs and
mRNA expression in human macrophages regulated by interleukin-27.
Int J Mol Sci. 20:62072019. View Article : Google Scholar
|
|
8
|
Wang M, Zhou L, Yu F, Zhang Y, Li P and
Wang K: The functional roles of exosomal long non-coding RNAs in
cancer. Cell Mol Life Sci. 76:2059–2076. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang F, Zhang L and Zhang C: Long
noncoding RNAs and tumorigenesis: Genetic associations, molecular
mechanisms, and therapeutic strategies. Tumour Biol. 37:163–175.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zheng M, Hu Y, Gou R, Nie X, Li X, Liu J
and Lin B: Identification three LncRNA prognostic signature of
ovarian cancer based on genome-wide copy number variation. Biomed
Pharmacother. 124:1098102020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lv Y, Wei W, Huang Z, Chen Z, Fang Y, Pan
L, Han X and Xu Z: Long non-coding RNA expression profile can
predict early recurrence in hepatocellular carcinoma after curative
resection. Hepatol Res. 48:1140–1148. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang Y, Li Y, Wang Q, Zhang X, Wang D,
Tang HC, Meng X and Ding X: Identification of an lncRNAmiRNAmRNA
interaction mechanism in breast cancer based on bioinformatic
analysis. Mol Med Rep. 16:5113–5120. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shen CJ, Cheng YM and Wang CL: LncRNA PVT1
epigenetically silences miR-195 and modulates EMT and
chemoresistance in cervical cancer cells. J Drug Target.
25:637–644. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li R, Liu J and Qi J: Knockdown of long
non-coding RNA CCAT1 suppresses proliferation and EMT of human
cervical cancer cell lines by down-regulating Runx2. Exp Mol
Pathol. 113:1043802020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Subramanian A, Tamayo P, Mootha VK,
Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub
TR, Lander ES and Mesirov JP: Gene set enrichment analysis: A
knowledge-based approach for interpreting genome-wide expression
profiles. Proc Natl Acad Sci USA. 102:15545–15550. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yu G, Wang LG, Han Y and He QY:
clusterProfiler: An R package for comparing biological themes among
gene clusters. OMICS. 16:284–287. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hu R and Lu Z: Long non-coding RNA HCP5
promotes prostate cancer cell proliferation by acting as the sponge
of miR-4656 to modulate CEMIP expression. Oncol Rep. 43:328–336.
2020.PubMed/NCBI
|
|
19
|
Bai J, Xu J, Zhao J and Zhang R: LncRNA
NBR2 suppresses migration and invasion of colorectal cancer cells
by downregulating miRNA-21. Hum Cell. 33:98–103. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liang H, Zhang C, Guan H, Liu J and Cui Y:
LncRNA DANCR promotes cervical cancer progression by upregulating
ROCK1 via sponging miR-335-5p. J Cell Physiol. 234:7266–7278. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sanchez Calle A, Kawamura Y, Yamamoto Y,
Takeshita F and Ochiya T: Emerging roles of long non-coding RNA in
cancer. Cancer Sci. 109:2093–2100. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dong P, Xiong Y, Yue J, Xu D, Ihira K,
Konno Y, Kobayashi N, Todo Y and Watari H: Long noncoding RNA NEAT1
drives aggressive endometrial cancer progression via
miR-361-regulated networks involving STAT3 and tumor
microenvironment-related genes. J Exp Clin Cancer Res. 38:2952019.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang J, Li Z, Liu L, Wang Q, Li S, Chen
D, Hu Z, Yu T, Ding J, Li J, et al: Long noncoding RNA TSLNC8 is a
tumor suppressor that inactivates the interleukin-6/STAT3 signaling
pathway. Hepatology. 67:171–187. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ghafouri-Fard S and Taheri M: Maternally
expressed gene 3 (MEG3): A tumor suppressor long non coding RNA.
Biomed Pharmacother. 118:1091292019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yao Y, Zhang T, Qi L, Zhou C, Wei J, Feng
F, Liu R and Sun C: Integrated analysis of co-expression and ceRNA
network identifies five lncRNAs as prognostic markers for breast
cancer. J Cell Mol Med. 23:8410–8419. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen X, Chen Z, Yu S, Nie F, Yan S, Ma P,
Chen Q, Wei C, Fu H, Xu T, et al: Long noncoding RNA LINC01234
functions as a competing endogenous RNA to regulate CBFB expression
by sponging miR-204-5p in gastric cancer. Clin Cancer Res.
24:2002–2014. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lu W, Zhang H, Niu Y, Wu Y, Sun W, Li H,
Kong J, Ding K, Shen HM, Wu H, et al: Long non-coding RNA linc00673
regulated non-small cell lung cancer proliferation, migration,
invasion and epithelial mesenchymal transition by sponging
miR-150-5p. Mol Cancer. 16:1182017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Qiu BQ, Lin XH, Ye XD, Huang W, Pei X,
Xiong D, Long X, Zhu SQ, Lu F, Lin K, et al: Long non-coding RNA
PSMA3-AS1 promotes malignant phenotypes of esophageal cancer by
modulating the miR-101/EZH2 axis as a ceRNA. Aging. 12:1843–1856.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lin W, Ye H, You K and Chen L:
Up-regulation of circ_LARP4 suppresses cell proliferation and
migration in ovarian cancer by regulating miR-513b-5p/LARP4 axis.
Cancer Cell Int. 20:52020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang X, Zhang X, Wang G, Wang L, Lin Y and
Sun F: Hsa-miR-513b-5p suppresses cell proliferation and promotes
P53 expression by targeting IRF2 in testicular embryonal carcinoma
cells. Gene. 626:344–353. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yao H, Kong F and Zhou Y: MiR-182 promotes
cell proliferation, migration and invasion by targeting FoxF2 in
endometrial carcinoma cells. Int J Clin Exp Pathol. 12:1248–1259.
2019.PubMed/NCBI
|
|
32
|
Lv Y, Ye D, Qiu S, Zhang J, Shen Z, Shen Y
and Deng H: MiR-182 regulates cell proliferation and apoptosis in
laryngeal squamous cell carcinoma by targeting the CRR9. Biosci
Rep. 39:BSR201913482019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ngeow J, Sesock K and Eng C: Breast cancer
risk and clinical implications for germline PTEN mutation carriers.
Breast Cancer Res Treat. 165:1–8. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Patel R, Brzezinska EA, Repiscak P, Ahmad
I, Mui E, Gao M, Blomme A, Harle V, Tan EH, Malviya G, et al:
Activation of β-catenin cooperates with loss of Pten to drive
AR-independent castration-resistant prostate cancer. Cancer Res.
80:576–590. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kaur G, Balasubramaniam SD and Lee YJ:
IGFBP-2 in cervical cancer development. Exp Mol Pathol. 113:212020.
View Article : Google Scholar
|
|
36
|
Li A, Qiu M, Zhou H, Wang T and Guo W:
PTEN, insulin resistance and cancer. Curr Pharm Des. 23:3667–3676.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Shao S, Wang C, Wang S, Zhang H and Zhang
Y: LncRNA STXBP5-AS1 suppressed cervical cancer progression via
targeting miR-96-5p/PTEN axis. Biomed Pharmacother. 117:152019.
View Article : Google Scholar
|
|
38
|
Wang S, Jiang W, Zhang X, Lu Z, Geng Q,
Wang W, Li N and Cai X: LINC-PINT alleviates lung cancer
progression via sponging miR-543 and inducing PTEN. Cancer Med.
9:1999–2009. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Shi YP, Liu GL, Li S and Liu XL: miR-17-5p
knockdown inhibits proliferation, autophagy and promotes apoptosis
in thyroid cancer via targeting PTEN. Neoplasma. 67:249–258. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Fu BM: Tumor metastasis in the
microcirculation. Adv Exp Med Biol. 1097:201–218. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ombrato L and Malanchi I: The EMT
universe: Space between cancer cell dissemination and metastasis
initiation. Crit Rev Oncog. 19:349–361. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Odero-Marah V, Hawsawi O, Henderson V and
Sweeney J: Epithelial-mesenchymal transition (EMT) and prostate
cancer. Adv Exp Med Biol. 1095:101–110. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Liang H, Yu T, Han Y, Jiang H, Wang C, You
T, Zhao X, Shan H, Yang R, Yang L, et al: LncRNA PTAR promotes EMT
and invasion-metastasis in serous ovarian cancer by competitively
binding miR-101-3p to regulate ZEB1 expression. Mol Cancer.
17:1192018. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Li ZT, Zhang X, Wang DW, Xu J, Kou KJ,
Wang ZW, Yong G, Liang DS and Sun XY: Overexpressed lncRNA
GATA6-AS1 inhibits LNM and EMT via FZD4 through the Wnt/β-catenin
signaling pathway in GC. Mol Ther Nucleic Acids. 19:827–840. 2019.
View Article : Google Scholar : PubMed/NCBI
|
